Skip to navigation Skip to content



About this Medication
  • Brand Name: Mavenclad®
  • Chemical Name: Cladribine
  • Usage in MS: Disease-Modifying Agent
  • Generic Available: No

This is an oral medication in tablet form.


Mavenclad® is a compound that targets certain types of white blood cells (lymphocytes) that drive the immune attack in MS. It temporarily reduces the number of both T and B lymphocytes without continuous suppression of the immune system.

Mavenclad® is approved by the FDA for adults with relapsing forms of multiple sclerosis, to include relapsing-remitting disease and active secondary progressive disease. Because of its safety profile, use of Mavenclad is generally recommended for patients who have had an inadequate response to, or are unable to tolerate, an alternate drug indicated for the treatment of MS.
Click here to read the Prescribing Information for healthcare providers. 

Click here to read the Medication Guide for patients.


MS LifeLines®

Financial Assistance Program

MS LifeLines®


Your input is important!

We believe that people affected by MS live better lives when they're connected.  To help us provide you with the best resources, support and information, please provide your feedback in a short survey.
Take the survey